Aberdeen Group plc Purchases 62,263 Shares of GE HealthCare Technologies Inc. $GEHC

Aberdeen Group plc boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 55.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 174,328 shares of the company’s stock after acquiring an additional 62,263 shares during the quarter. Aberdeen Group plc’s holdings in GE HealthCare Technologies were worth $13,092,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. Norges Bank purchased a new stake in GE HealthCare Technologies in the second quarter worth approximately $468,120,000. Holocene Advisors LP grew its position in GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after purchasing an additional 2,581,522 shares during the period. Menora Mivtachim Holdings LTD. purchased a new stake in GE HealthCare Technologies during the 2nd quarter valued at $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new stake in shares of GE HealthCare Technologies during the 2nd quarter valued at about $58,388,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $83.01 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $93.14. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The stock has a fifty day simple moving average of $82.26 and a two-hundred day simple moving average of $77.88. The stock has a market capitalization of $37.83 billion, a price-to-earnings ratio of 18.20, a P/E/G ratio of 1.83 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.07%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Evercore upped their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Piper Sandler upped their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Morgan Stanley raised their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Finally, Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and a consensus target price of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.